Navidea Biopharmaceuticals Cash Conversion Cycle | NAVB

Annual Cash Conversion Cycle Navidea Biopharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-279 K	1.06 K	-366 K	-41.8 K	-1.14 K	-295 K	-890	-182	49.3	-19.7	77.4	4.82	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.06 K	-366 K	-81.9 K

Quarterly Cash Conversion Cycle Navidea Biopharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-116 K	-323 K	-	-	-	-	1.1 K	-	-1.1 M	-253 K	-157 K	-	-520 K	-426 K	-10.4 K	-	-1.01 K	-1.09 K	-182 K	-	3.32 K	1.21 K	656	-	10.2	15.9	10.3	-	42.9	70.7	50.4	71.3	94.6	71.2	143	174	415	821	-	-	-	-	-	-	366	29.3	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.32 K	-1.1 M	-103 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AnaptysBio ANAB	205	$ 51.7	1.83 %	$ 1.5 B	USA
Bicycle Therapeutics plc BCYC	13.8	$ 3.73	3.61 %	$ 258 M	Britain
Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	5.06	-	-	$ 401 M	USA
BioMarin Pharmaceutical BMRN	733	$ 61.35	0.06 %	$ 11.8 B	USA
Benitec Biopharma BNTC	141	$ 9.64	0.46 %	$ 449 M	USA
Genocea Biosciences GNCA	24.9	-	-15.0 %	$ 3.04 M	USA
G1 Therapeutics GTHX	52.6	-	-	$ 370 M	USA
Catalyst Biosciences CBIO	285	$ 14.24	0.35 %	$ 1.27 B	USA
C4 Therapeutics CCCC	27.9	$ 3.03	0.3 %	$ 251 M	USA
Codexis CDXS	-15.2	$ 1.37	1.45 %	$ 119 M	USA
Cerus Corporation CERS	47	$ 2.61	0.38 %	$ 497 M	USA
AbbVie ABBV	284	$ 265.12	0.09 %	$ 469 B	USA
Humanigen HGEN	598	-	-81.12 %	$ 4.28 M	USA
Coherus BioSciences CHRS	149	$ 1.17	1.48 %	$ 137 M	USA
AbCellera Biologics ABCL	173	$ 12.65	2.76 %	$ 3.78 B	Canada
Abeona Therapeutics ABEO	-695	$ 5.43	2.65 %	$ 288 M	USA
Celldex Therapeutics CLDX	-3.74 K	$ 31.48	1.16 %	$ 2.09 B	USA
CollPlant Biotechnologies Ltd. CLGN	-90.5	$ 4.12	1.98 %	$ 50.3 M	Israel
Фармсинтез LIFE	-15.9	-	-	-	Russia
Karuna Therapeutics KRTX	15.9	-	-	$ 12.2 B	USA
Cocrystal Pharma COCP	51.2	$ 1.15	1.67 %	$ 13 M	USA
Crinetics Pharmaceuticals CRNX	-4.27 K	$ 84.95	0.13 %	$ 7.99 B	USA
Collegium Pharmaceutical COLL	537	$ 22.64	0.85 %	$ 717 M	USA
Corcept Therapeutics Incorporated CORT	-402	$ 118.51	4.93 %	$ 12.3 B	USA
Chimerix CMRX	52.5	-	-	$ 756 M	USA
Curis CRIS	64.7	$ 0.88	0.85 %	$ 11.6 M	USA
CorMedix CRMD	359	$ 7.77	1.04 %	$ 560 K	USA
CRISPR Therapeutics AG CRSP	1.3 K	$ 55.7	0.23 %	$ 5.01 B	Schweiz
Champions Oncology CSBR	9.02	$ 4.95	0.38 %	$ 68.5 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.88	0.62 %	$ 935 M	Canada
Cue Biopharma CUE	43.1	$ 32.85	3.6 %	$ 3.11 B	USA